Mylan Ireland Ltd Company Profile
✉ Email this page to a colleague
What is the competitive landscape for MYLAN IRELAND LTD, and when can generic versions of MYLAN IRELAND LTD drugs launch?
MYLAN IRELAND LTD has five approved drugs.
There are nineteen US patents protecting MYLAN IRELAND LTD drugs.
There are sixty-four patent family members on MYLAN IRELAND LTD drugs in thirty-one countries and one supplementary protection certificate in one country.
Summary for Mylan Ireland Ltd
International Patents: | 64 |
US Patents: | 19 |
Tradenames: | 4 |
Ingredients: | 4 |
NDAs: | 5 |
Drugs and US Patents for Mylan Ireland Ltd
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mylan Ireland Ltd | YUPELRI | revefenacin | SOLUTION;INHALATION | 210598-001 | Nov 9, 2018 | RX | Yes | Yes | 11,691,948 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Mylan Ireland Ltd | YUPELRI | revefenacin | SOLUTION;INHALATION | 210598-001 | Nov 9, 2018 | RX | Yes | Yes | 8,273,894 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Mylan Ireland Ltd | YUPELRI | revefenacin | SOLUTION;INHALATION | 210598-001 | Nov 9, 2018 | RX | Yes | Yes | 7,585,879 | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | ||
Mylan Ireland Ltd | ARIXTRA | fondaparinux sodium | INJECTABLE;SUBCUTANEOUS | 021345-003 | May 28, 2004 | AP | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Mylan Ireland Ltd | ARIXTRA | fondaparinux sodium | INJECTABLE;SUBCUTANEOUS | 021345-002 | May 28, 2004 | AP | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Mylan Ireland Ltd | PRETOMANID | pretomanid | TABLET;ORAL | 212862-001 | Aug 14, 2019 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Mylan Ireland Ltd
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Mylan Ireland Ltd | MIACALCIN | calcitonin salmon | SPRAY, METERED;NASAL | 020313-002 | Aug 17, 1995 | 5,759,565 | ⤷ Try a Trial |
Mylan Ireland Ltd | ARIXTRA | fondaparinux sodium | INJECTABLE;SUBCUTANEOUS | 021345-001 | Dec 7, 2001 | 4,818,816 | ⤷ Try a Trial |
Mylan Ireland Ltd | MIACALCIN | calcitonin salmon | SPRAY, METERED;NASAL | 020313-002 | Aug 17, 1995 | 5,733,569 | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for Mylan Ireland Ltd Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
South Africa | 200607099 | ⤷ Try a Trial |
Spain | 2306125 | ⤷ Try a Trial |
European Patent Office | 1723114 | ⤷ Try a Trial |
Japan | 2017171692 | ⤷ Try a Trial |
Hungary | E026414 | ⤷ Try a Trial |
World Intellectual Property Organization (WIPO) | 2020047225 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Mylan Ireland Ltd Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0084999 | 2002C/012 | Belgium | ⤷ Try a Trial | PRODUCT NAME: FONDAPARINUX SODIQUE; REGISTRATION NO/DATE: EU/1/02/206/001 20020321 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.